Previous 10 | Next 10 |
ADES, AGM, AIV, AKBA, ALCO, ALTO, AMC, AMPH, AMWL, ANGI, APPF, APTO, ARCT, AROC, ASLE, ASRT, ATER, AVIR, AZTA, BATL, BHF, BLFS, BLI, BLNK, BODY, OTCPK:BOWFF, BRMK, BRT, BW, BWXT, CAPL, CARA, CARG, CHMI, CLAR, CLOV, CNNE, CSTL, OTCPK:CURLF, DDD, DHT, DNB, ENTA, EQH, EVBG, FCRD, FF, FGEN, FLL, ...
Piper Sandler has downgraded the Ireland-based drugmaker Endo International (NASDAQ:ENDP) to Underweight from Neutral, noting the impact of generic competition on the company’s vasopressin injection, Vasostrict. With its 1Q 2022 financials on Thursday, Endo (ENDP) reported a ~30% YoY r...
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 2, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2022 ended March 31, 2022, after the market closes on Monday, May 9 th 2022, and will hold a conference call to discuss it...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event. For further details see: Amphastar Pharmaceuticals (AMPH) Presents At 21st Annual Virtual Healthcare Conference - Slideshow
The U.S. Food and Drug Administration approved Amphastar Pharmaceuticals' (NASDAQ:AMPH) generic Ganirelix Acetate Injection, 250mg/0.5mL in a prefilled syringe. The company said Ganirelix acetate injection is used for the inhibition of premature luteinizing hormone (LH) surges in women u...
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 8, 2022 / Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for Ganirelix Acetate Injection, 250mg/0.5mL in a prefilled syr...
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 6, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Ex...
Investors have seen some respite early this week from the tough market conditions that have prevailed throughout much of 2022 thus far. However, the Nasdaq Composite (NASDAQINDEX: ^IXIC) turned lower on Wednesday, trading down more than three-quarters of a percent as of 1:30 p.m. ET...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Don’t expect the massive volatility we’re experiencing to end soon. That’s why “A”-rated stocks are crucial to your portfolio now. While the pandemic and then the Russian invasion of Ukr...
Volt Information Sciences (NYSE:VOLT) +96% on acquisition proposal from ACS Solutions affiliate. Zhongchao (NASDAQ:ZCMD) +41%. Turquoise Hill Resources (NYSE:TRQ) +31% after receiving Rio Tinto's takeover proposal. Amphastar Pharmaceuticals (NASDAQ:AMPH) +24%. Mullen Autom...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...